Molecular Pathology Laboratory Network

MPLN Launches New Website


Molecular Pathology Laboratory Network, Inc. (MPLN) recently announced the redesign of its website at www.mplnet.com.

The new and improved site is part of MPLN's mission to continually meet the needs of its clients by hosting a website that is user friendly and informative. The improved navigation and usability allow users to easily move throughout the site and search for information on technology, tests and industry news. MPLN also improved its test menu, which now allows users to search tests alphabetically, by category or disease. In addition to these updates, the site also provides a timeline that highlights MPLN's 20 years of success in the healthcare industry.

MPLN is a privately held molecular diagnostic laboratory founded in 1989 and headquartered in Maryville, Tenn. A leader in laboratory medicine, MPLN offers a comprehensive selection of molecular diagnostics and cytogenetic testing that targets oncology, women's health, prenatal care, medical genetics and pharmacogenetics and infectious disease.

The laboratory also has extensive expertise in chromosome analysis, flow cytometry, fluorescence in situ hybridization (FISH), real-time and quantitative polymerase chain reaction technologies, immunohistochemistry and gene sequencing.

MPLN is certified by the Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of Tennessee, Florida, New York and Maryland.